费布里病呈现为末期高伤心肌病:诊断陷和经验教训
José Victor da Nóbrega Borges1, Samira Abdel Correia Leila2
1Florida International University and Baptist Health South Florida, Miami, Florida, USA.
JACC. Case reports
|November 15, 2025
概括
费布里病 (FD) 可以模仿多变性心肌病 (HCM),延迟诊断. 通过综合测试进行早期识别对于治疗这种心脏存储障碍至关重要.
科学领域:
- 心脏病学 心脏病学
- 遗传学 遗传学 是一个
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 费布里病 (FD) 可以呈现为孤立的心脏缩,模仿高缩性心肌病 (HCM).
- 这种表现可能会推迟FD的诊断,FD是一种可治疗的溶酶体储存障碍.
研究的目的:
- 突出诊断在区分心脏法布里病与高伤心肌病的诊断挑战.
- 强调对罕见遗传疾病的综合诊断方法的重要性.
主要方法:
- 一名64岁的男性因疑似HCM而心力衰竭的病例报告.
- 分析包括心声学,心脏病理学解释,α-银酸酶A酶测定和遗传测试.
主要成果:
- 病理学发现肌细胞真空化,导致对溶酶体储存障碍的调查.
- 酶测定显示α-galactosidase A活性降低,遗传测试确定了一种致病变体 (p.Asn215Ser).
结论:
- 先进的法布里病可以模仿HCM,特别是在没有典型的心脏外症状的晚期发病形式.
- 准确的诊断需要整合组织病理学,酶检测和针对性治疗的基因分析.
- 组织学发现表明代谢障碍需要进一步调查,即使是在心脏移植后.
相关概念视频
Cardiomyopathy III: Hypertrophic Cardiomyopathy
380
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
380
Cardiomyopathy V: Interprofessional Care
323
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
323
Cardiomyopathy II: Dilated Cardiomyopathy
451
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
451
Cardiomyopathy IV: Restrictive Cardiomyopathy
438
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
438
Heart Failure II: Pathophysiology
695
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
695
Cardiomyopathy I: Introduction and Classification
488
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
488


